-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Scinai Immunotherapeutics Ltd. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from 2021 to 2023.
- Scinai Immunotherapeutics Ltd. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was -$6K, a 98.8% increase year-over-year.
- Scinai Immunotherapeutics Ltd. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$637K, a 23.8% increase from 2022.
- Scinai Immunotherapeutics Ltd. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$836K, a 501% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)